Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Journal of the American Society of Nephrology : JASN|February 10, 2006
IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohortYongmei Liu, Yvette Berthier-Schaad, Margaret D Fallin, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American familiesL Ebony Boulware, Lucy A Meoni, Nancy E Fink, et al.JAMA|April 5, 2007
Statin use and sepsis events [corrected] in patients with chronic kidney diseaseRajesh Gupta, Laura C Plantinga, Nancy E Fink, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohortYongmei Liu, Yvette Berthier-Schaad, Nancy E Fink, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 8, 2010
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) StudyTariq Shafi, Bernard G Jaar, Laura C Plantinga, et al.BMC Nephrology|February 10, 2009
Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective studyBernard G Jaar, Laura C Plantinga, Deidra C Crews, et al.Journal of the American Society of Nephrology : JASN|December 8, 2004
Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patientsLaura C Plantinga, Nancy E Fink, Bernard G Jaar, et al.Journal of the American Society of Nephrology : JASN|February 24, 2004
Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measuresAlbert W Wu, Nancy E Fink, Jane V R Marsh-Manzi, et al.Kidney International|February 19, 2002
Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: the CHOICE StudyBrad C Astor, Joseph A Eustace, Michael J Klag, et al.Thrombosis and Haemostasis|September 4, 2008
Heparin-induced antibodies and cardiovascular risk in patients on dialysisLars M Asmis, Jodi B Segal, Laura C Plantinga, et al.Pageof 7